We have reported a frameshift mutation of the DOK1 gene in chronic lymphoid leukemia (CLL) resulting in the expression of truncated DOK1 that is exclusively localized in the nucleus and loses its tumor suppressive activities, in contrast with the cytoplasmic wild type protein [8]. Here, DOK1 is linked to neoplasm.